Eyebright Medical Technology Beijing Co Ltd
SSE:688050
EV/IC
Enterprise Value to IC
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
Market Cap | EV/IC | ||||
---|---|---|---|---|---|
CN |
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
8B CNY | 4.6 | ||
CH |
Alcon AG
SIX:ALC
|
40.3B CHF | 1.8 | ||
JP |
Hoya Corp
TSE:7741
|
6.7T JPY | 11 | ||
DK |
Coloplast A/S
CSE:COLO B
|
187.4B DKK | 4.5 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19B USD | 3.5 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.9B USD | 1.8 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58B CNY | 11.6 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5B GBP | 39 | ||
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.4B CHF | 5.6 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.6B USD | 1.1 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.7T KRW | 10.6 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.